PsychRounds: The Psychiatry Podcast

1. A Validity-Based Diagnostic Hierarchy with Dr. Mark Ruffalo and Dr. Ronald Pies

   November 4, 202654 minPlay next

   Today, we welcome back a former guest, Dr. Mark Ruffalo, and joining him is his colleague and co-author, Dr. Ronald Pies. We will be discussing their recently published article, The Need For A Validity-Based …

   Show notes

   Today, we welcome back a former guest, Dr. Mark Ruffalo, and joining him is his colleague and co-author, Dr. Ronald Pies. We will be discussing their recently published article, The Need For A Validity-Based Hierarchy In DSM-6.

   
   

   Article: https://pubmed.ncbi.nlm.nih.gov/42908074/

   Dr. Ruffalo Website: https://www.drruffalo.com/

   Dr. Pies Psychiatric Times Profile: https://www.psychiatrictimes.com/authors/ronald-w-pies-md

2. A New Long-Acting Injectable: Olanzapine (Zyprexa) Weltruza

   October 21, 202625 minPlay next

   Today, we're covering the recent FDA approval of a new Olanzapine long-acting injectable - Weltruza.References: https://pubmed.ncbi.nlm.nih.gov/41632432/https://pubmed.ncbi.nlm.nih.gov/42198294/https://www.tevap …

   Show notes

   Today, we're covering the recent FDA approval of a new Olanzapine long-acting injectable - Weltruza.

   
   

   References:

   https://pubmed.ncbi.nlm.nih.gov/41632432/

   https://pubmed.ncbi.nlm.nih.gov/42198294/

   https://www.tevapharm.com/news-and-media/latest-news/new-long-term-safety-data-from-the-completed-phase-3-solaris-trial-support-the-potential-of-olanzapine-la/

   
   

3. Pharmacogenetic Testing in Psychiatry

   October 7, 202622 minPlay next

   Welcome back, everyone! We’re back after PRITE, and today we’re discussing pharmacogenetic testing.

4. GLP-1 Agonists (Ozempic, Wegovy) in Psychiatry

   September 16, 202633 minPlay next

   Today, we will discuss GLP-1's and the emerging use of this class of medications in psychiatry.Sources:https://pubmed.ncbi.nlm.nih.gov/42247271/https://pmc.ncbi.nlm.nih.gov/articles/PMC11441540/https://jamanetwo …

   Show notes

   Today, we will discuss GLP-1's and the emerging use of this class of medications in psychiatry.

   
   

   Sources:

   https://pubmed.ncbi.nlm.nih.gov/42247271/

   https://pmc.ncbi.nlm.nih.gov/articles/PMC11441540/

   https://jamanetwork.com/journals/jamapsychiatry/article-abstract/2838205

   https://pubmed.ncbi.nlm.nih.gov/42070571

   https://pubmed.ncbi.nlm.nih.gov/41806782/

   
   

5. Landmark Studies: The STAR*D Trial

   September 2, 202628 minPlay next

   We resume our landmark studies series looking at the pivotal study in Major Depressive Disorder (MDD), The STAR*D (Sequenced Treatment Alternatives to Relieve Depression) …

   Show notes

   We resume our landmark studies series looking at the pivotal study in Major Depressive Disorder (MDD), The STAR*D (Sequenced Treatment Alternatives to Relieve Depression) trial.

   
   

   References:

   https://pubmed.ncbi.nlm.nih.gov/12778843/

   https://pubmed.ncbi.nlm.nih.gov/19880458/

   https://jamanetwork.com/journals/jamapsychiatry/fullarticle/482026

   https://pubmed.ncbi.nlm.nih.gov/15061154/

   https://pubmed.ncbi.nlm.nih.gov/20370962/

   https://pubmed.ncbi.nlm.nih.gov/37491091/

   
   

   
   

6. Dogs in Mental Health with Dr. Nancy Gee: A Biopsychosocial Approach

   August 19, 202655 minPlay next

   We have a special guest today to talk about one of our favorite topics... dogs! Most people might intuitively say that they feel like their dogs improve their mental health, but today, we look at the science …

   Show notes

   We have a special guest today to talk about one of our favorite topics... dogs! Most people might intuitively say that they feel like their dogs improve their mental health, but today, we look at the science with the leading expert on the subject.

   
   

   Dr. Nancy Gee Profile: https://medschool.vcu.edu/about/portfolio/details/geen2/

   
   

   References:

   Dogs Supporting Human Health and Well-Being: A Biopsychosocial Approach:

   https://pubmed.ncbi.nlm.nih.gov/33860004/

   Randomized Controlled Trials: https://pmc.ncbi.nlm.nih.gov/articles/PMC12728353/, https://pmc.ncbi.nlm.nih.gov/articles/PMC11714157/

   
   

7. Centanafadine (Simtriyo): A New Medication for ADHD

   August 5, 202628 minPlay next

   Welcome back! Today, we are talking about Simtriyo, which has generated a lot of media attention recently given a newly minted FDA approval for ADHD.References …

   Show notes

   Welcome back! Today, we are talking about Simtriyo, which has generated a lot of media attention recently given a newly minted FDA approval for ADHD.

   
   

   References

   https://pmc.ncbi.nlm.nih.gov/articles/PMC12314114/

   https://pmc.ncbi.nlm.nih.gov/articles/PMC12379780/

   https://pubmed.ncbi.nlm.nih.gov/31776871/

   https://pubmed.ncbi.nlm.nih.gov/40619095/

   https://pubmed.ncbi.nlm.nih.gov/28731336/

   https://pmc.ncbi.nlm.nih.gov/articles/PMC9426730/

8. Landmark Studies: The CATIE Trial

   July 22, 202622 minPlay next

   Today we're starting a new type of series - looking at some of the most seminal studies in psychiatry. We're going to start with the CATIE Trial, which was published in 2005. References …

   Show notes

   Today we're starting a new type of series - looking at some of the most seminal studies in psychiatry. We're going to start with the CATIE Trial, which was published in 2005.

   
   

   References:

   https://www.nejm.org/doi/full/10.1056/NEJMoa051688

   https://pubmed.ncbi.nlm.nih.gov/19594194/

   https://pubmed.ncbi.nlm.nih.gov/17924259/

   https://pubmed.ncbi.nlm.nih.gov/17286522/

   https://www.nejm.org/doi/full/10.1056/NEJMoa061240

   https://jamanetwork.com/journals/jamapsychiatry/fullarticle/209844

   
   

   
   

   
   

9. The Rising Use of Recreational Kratom

   July 8, 202621 minPlay next

   Apologies for our little hiatus - a couple of us had cross-country moves in June. But we're back! Today we have an episode on the rising use of recreational Kratom and pertinent tidbits to know from a …

   Show notes

   Apologies for our little hiatus - a couple of us had cross-country moves in June. But we're back! Today we have an episode on the rising use of recreational Kratom and pertinent tidbits to know from a psychiatry standpoint.

   
   

   References:

   
   

   • https://pmc.ncbi.nlm.nih.gov/articles/PMC8924421/

   • https://www.ncbi.nlm.nih.gov/books/NBK585120/

   • https://pmc.ncbi.nlm.nih.gov/articles/PMC10846393/

   • https://pmc.ncbi.nlm.nih.gov/articles/PMC10177737/

10. Modafinil (Provigil)

    June 3, 202620 minPlay next

    Welcome back! Today, we are looking at Modafinil and it's nuanced use in psychiatry.References:Provigil (modafinil) [prescribing information]. North Wales, PA: Teva Pharmaceuticals USA, Inc. U.S. Food and Drug …

    Show notes

    Welcome back! Today, we are looking at Modafinil and it's nuanced use in psychiatry.

    
    

    References:

    1. Provigil (modafinil) [prescribing information]. North Wales, PA: Teva Pharmaceuticals USA, Inc. U.S. Food and Drug Administration. Available at: https://www.accessdata.fda.gov/drugsatfdadocs/label/2015/020717s037s038lbl.pdf

    2. Schwartz JR. Modafinil in the treatment of excessive sleepiness. Drug Des Devel Ther. 2009;2:71–85.

    3. Kaplan S, Goehring EL Jr, Engel T, et al. Cardiovascular outcomes associated with modafinil in patients with obstructive sleep apnea. Pharmacoepidemiol Drug Saf. 2018;27(11):1182–1190. doi:10.1002/pds.4642

    4. Cortese S, Adamo N, Del Giovane C, et al. Comparative efficacy and tolerability of medications for attention-deficit hyperactivity disorder in children, adolescents, and adults: a systematic review and network meta-analysis. Lancet Psychiatry. 2018;5(9):727–738. doi:10.1016/S2215-0366(18)30269-4

    5. Goss AJ, Kaser M, Costafreda SG, Sahakian BJ, Fu CH. Modafinil augmentation therapy in unipolar and bipolar depression: a systematic review and meta-analysis of randomized controlled trials. J Clin Psychiatry. 2013;74(11):1101–1107. doi:10.4088/JCP.13r08560

    6. Bahji A, Mesbah-Oskui L. Comparative efficacy and safety of stimulant-type medications for depression: a systematic review and network meta-analysis. J Affect Disord. 2021;292:416–423. doi:10.1016/j.jad.2021.05.119

    7. Nunez NA, Singh B, Jorgensen A, et al. Efficacy and tolerability of adjunctive modafinil/armodafinil in bipolar depression: a meta-analysis of randomized controlled trials. Bipolar Disord. 2020;22(2):109–120. doi:10.1111/bdi.12859

11. Naltrexone

    May 20, 202616 minPlay next

    Welcome Back! Today we are discussing the medication Naltrexone and its uses in psychiatry. References: https://www.ncbi.nlm.nih.gov/books/NBK534811/https://pubmed.ncbi.nlm.nih.gov/24825644/https://pubmed.ncbi.n …

    Show notes

    Welcome Back! Today we are discussing the medication Naltrexone and its uses in psychiatry.

    
    

    References:

    • https://www.ncbi.nlm.nih.gov/books/NBK534811/

    • https://pubmed.ncbi.nlm.nih.gov/24825644/

    • https://pubmed.ncbi.nlm.nih.gov/26798982/

    • https://www.nejm.org/doi/full/10.1056/NEJMct0801733

    • https://pubmed.ncbi.nlm.nih.gov/26798982/

    
    

12. Placebo Effect and Response in Psychiatry

    May 6, 202622 minPlay next

    Welcome back! Today, we will be discussing the placebo effect.References:https://pubmed.ncbi.nlm.nih.gov/16503356/https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6003660/https://www.ncbi.nlm.nih.gov/pmc/articles/PM …

    Show notes

    Welcome back! Today, we will be discussing the placebo effect.

    
    

    References:

    https://pubmed.ncbi.nlm.nih.gov/16503356/

    https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6003660/

    https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8556377/

    https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3714297/

    https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6694178/

    https://www.psychiatrypodcast.com/psychiatry-psychotherapy-podcast/2018/11/19/understanding-placebo
    

13. Amantadine (Symmetrel)

    April 8, 202617 minPlay next

    Welcome back! Today we are talking all about Amantadine, and it's uses in psychiatry.

14. VMAT2 Inhibitors: Valbenazine (Ingrezza) and Deutetrabenazine (Austedo)

    March 21, 202617 minPlay next

    Welcome back! Today we are featuring the two FDA-approved medications for tardive dyskinesia, the VMAT2 inhibitors Valbenazine (Ingrezza) and Deutetrabenazine (Austedo). References …

    Show notes

    Welcome back! Today we are featuring the two FDA-approved medications for tardive dyskinesia, the VMAT2 inhibitors Valbenazine (Ingrezza) and Deutetrabenazine (Austedo).

    
    

    References:

    https://pubmed.ncbi.nlm.nih.gov/41626799/

    https://www.ncbi.nlm.nih.gov/books/NBK548187/

    https://pubmed.ncbi.nlm.nih.gov/41626799/

    
    

15. A DSM Conversation with Dr. Allen Frances

    February 25, 202656 minPlay next

    We are back with another special guest episode! Please welcome Dr. Allen Frances, who was intricately involved in the formation of both the DSM III and DSM IV, the latter of which he served as …

    Show notes

    We are back with another special guest episode! Please welcome Dr. Allen Frances, who was intricately involved in the formation of both the DSM III and DSM IV, the latter of which he served as chair.

    
    

    https://x.com/AllenFrancesMD

    https://www.amazon.com/stores/author/B001HO76FU

    https://www.psychiatrictimes.com/authors/allen-frances-md

    
    

16. Topiramate (Topamax)

    January 28, 202615 minPlay next

    Welcome back! Today we will be doing a brief episode on Topiramate [Topamax], and its clinical uses in psychiatry.References:https://pubmed.ncbi.nlm.nih.gov/21438989/https://pubmed.ncbi.nlm.nih.gov/18774432/http …

    Show notes

    Welcome back! Today we will be doing a brief episode on Topiramate [Topamax], and its clinical uses in psychiatry.

    
    

    
    

    References:

    • https://pubmed.ncbi.nlm.nih.gov/21438989/

    • https://pubmed.ncbi.nlm.nih.gov/18774432/

    • https://pubmed.ncbi.nlm.nih.gov/25899459/

    • https://pmc.ncbi.nlm.nih.gov/articles/PMC1088011/

    • https://pmc.ncbi.nlm.nih.gov/articles/PMC2671954/

    • https://pubmed.ncbi.nlm.nih.gov/38706338/

    • https://pubmed.ncbi.nlm.nih.gov/20207521/

17. What Makes Something a Psychiatric Illness? Featuring Dr. Mark Ruffalo, MSW, DPsa

    January 14, 202655 minPlay next

    Welcome back, today we are discussing a deceptively difficult topic: What makes something a psychiatric illness? We are joined by our guest Dr. Mark Ruffalo. He is a psychotherapist in private practice in …

    Show notes

    Welcome back, today we are discussing a deceptively difficult topic: What makes something a psychiatric illness? We are joined by our guest Dr. Mark Ruffalo. He is a psychotherapist in private practice in Tampa, FL, and who also serves as Assistant Professor of Psychiatry at the University of Central Florida College of Medicine as well an Adjunct Assistant Professor of Psychiatry at Tufts University School of Medicine.

    Dr. Ruffalo's Website: https://www.drruffalo.com/

    Dr. Ruffalo's LinkedIn: https://www.linkedin.com/in/mark-l-ruffalo-71929063

    PRISM: https://www.psychiatrictimes.com/view/use-of-the-prism-diagnostic-instrument-in-clinical-practice

    PRISM Writing Contest: https://www.psychiatrictimes.com/view/prism-writing-contest-more-on-this-new-diagnostic-tool-from-mark-ruffalo-msw-dpsa

18. Lorazepam (Ativan)

    December 31, 202514 minPlay next

    Welcome back! Today we are at the highly prescribed and popular benzodiazepine Lorazepam, also known as Ativan. We look at its uses in psychiatry, especially catatonia. But despite anecdotal efficacy, does the …

    Show notes

    Welcome back! Today we are at the highly prescribed and popular benzodiazepine Lorazepam, also known as Ativan. We look at its uses in psychiatry, especially catatonia. But despite anecdotal efficacy, does the evidence hold up?

    
    

    References:

    • https://www.ncbi.nlm.nih.gov/books/NBK532890/

    • https://pubmed.ncbi.nlm.nih.gov/36805317/

    • https://pubmed.ncbi.nlm.nih.gov/6120058/

    • https://pubmed.ncbi.nlm.nih.gov/10229064/

    • https://psychopharmacologyinstitute.com/section/catatonia-diagnosis-the-lorazepam-challenge-2911-5899/

19. The Vitamin Series: Iron Deficiency in Psychiatry

    December 17, 202525 minPlay next

    Welcome back! Today we are embarking into the first of hopefully several episodes on the importance of vitamins and minerals in mental health. We will specifically be looking at the role of iron deficiency in …

    Show notes

    Welcome back! Today we are embarking into the first of hopefully several episodes on the importance of vitamins and minerals in mental health. We will specifically be looking at the role of iron deficiency in psychiatry and do an overview on some of the recent research that's been published.

    
    

    References:

    • https://www.ncbi.nlm.nih.gov/books/NBK557376/

    • https://www.sciencedirect.com/science/article/pii/S0268960X25000827#bb0165

    • https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2823909

    • https://www.sciencedirect.com/science/article/pii/S1389945717315599

    • https://pubmed.ncbi.nlm.nih.gov/40841680/

    • https://pubmed.ncbi.nlm.nih.gov/1677067/

    • https://www.thelancet.com/journals/eclinm/article/PIIS2589-5370(23)00463-7/fulltext

    • https://pmc.ncbi.nlm.nih.gov/articles/PMC6139360/

20. Nutritional Psychiatry with Dr. Laura Lachance

    December 3, 202549 minPlay next

    Welcome back! Today our topic is Nutritional Psychiatry and we've invited a special guest - Dr. Laura Lachance, who has done extensive research in the field. Along with Dr. Drew Ramsey, she has published a …

    Show notes

    Welcome back! Today our topic is Nutritional Psychiatry and we've invited a special guest - Dr. Laura Lachance, who has done extensive research in the field. Along with Dr. Drew Ramsey, she has published a paper looking at an Antidepressant Food Score or AFS and more recently, she was a part of the EASe-GAD trial, a study looking at the impact of omega-3 fatty acids on anxiety.

    
    

    Antidepressant Food Scale (AFS): https://pubmed.ncbi.nlm.nih.gov/30254980/

    EASe-GAD Trial: https://pubmed.ncbi.nlm.nih.gov/39316026/

    Gluten and Psychosis: https://pubmed.ncbi.nlm.nih.gov/24368154/

    Nutrition Worksheet for Patients: https://bmcpsychiatry.biomedcentral.com/articles/10.1186/s12888-021-03575-7

    Dr. Lachance's Instagram: https://www.instagram.com/preventivepsychiatry/

21. Stress, Culture, and Determinism with Dr. Robert Sapolsky

    November 19, 20251 h 3 minPlay next

    Welcome back! Today, we are hosting the highly accomplished Dr. Robert Sapolsky, PHD, a professor of professor of biology, neurology, and neurosurgery at Stanford University. He has had extensive research …

    Show notes

    Welcome back! Today, we are hosting the highly accomplished Dr. Robert Sapolsky, PHD, a professor of professor of biology, neurology, and neurosurgery at Stanford University. He has had extensive research particularly in the field of neuroendocrinology and chronic stress, which has acted as one of the foundations of modern psychoneuroendocrinology. He is also a research associate at the Institute of Primate Research in Kenya, with over 30 years of field research in Africa. He is also a renowned author, with major works including but not at all limited to Why Zebras Don’t Get Ulcers, Behave: The Biology of Humans at Our Best and Worst, and most recently, Determined: A Science of Life Without Free Will, which challenges us to reconsider free will, morality, and mental health itself through a scientific lens.

    More about Dr. Sapolsky: https://en.wikipedia.org/wiki/Robert_Sapolsky

    Dr. Sapolsky's Open Stanford Course: https://www.youtube.com/watch?v=-PpDq1WUtAw&list=PL848F2368C90DDC3D

    Dr. Sapolsky's Books: https://www.amazon.com/stores/author/B000APOCFE

    Dr. Sapolsky's Own Podcast:

    Spotify: https://open.spotify.com/show/0wDrkkznSB8S84kKuK9HCo

    Apple: https://podcasts.apple.com/us/podcast/robert-sapolsky-father-offspring-interviews/id1782280922

22. SSRIs Revisited: The 100th Episode

    November 5, 202533 minPlay next

    One hundred episodes later, let’s take it back to one of our very first, the Selective Serotonin Reuptake Inhibitors - with a much-needed update. Thank you to our guests, fans, and listeners.References …

    Show notes

    One hundred episodes later, let’s take it back to one of our very first, the Selective Serotonin Reuptake Inhibitors - with a much-needed update. Thank you to our guests, fans, and listeners.

    
    

    References:

    • https://pmc.ncbi.nlm.nih.gov/articles/PMC4428540/

      https://pubmed.ncbi.nlm.nih.gov/10333979⁠

      ⁠https://pmc.ncbi.nlm.nih.gov/articles/PMC3663330/⁠

    
    

    
    

    
    

23. Alprazolam (Xanax)

    October 29, 202515 minPlay next

    Welcome back! Today we have a very special episode on Alprazolam, brand-name Xanax. This benzodiazepine is one of the most commonly-prescribed and sought out psychotropic medications …

    Show notes

    Welcome back! Today we have a very special episode on Alprazolam, brand-name Xanax. This benzodiazepine is one of the most commonly-prescribed and sought out psychotropic medications.

    
    

    • https://www.ncbi.nlm.nih.gov/books/NBK538165/

    • https://pmc.ncbi.nlm.nih.gov/articles/PMC6769182/

    • https://pmc.ncbi.nlm.nih.gov/articles/PMC5846112/

    • https://pubmed.ncbi.nlm.nih.gov/6141930/

      https://pubmed.ncbi.nlm.nih.gov/17514187/

24. Climate Change and Mental Health with Dr. Ferdnand Osuagwu

    October 22, 202535 minPlay next

    Join us today for an episode on the impact of climate change on mental health. We'll be exploring concepts like eco-anxiety, advocacy, the impact of nuclear war and practical tips. We're joined by guest Dr …

    Show notes

    Join us today for an episode on the impact of climate change on mental health. We'll be exploring concepts like eco-anxiety, advocacy, the impact of nuclear war and practical tips.

    We're joined by guest Dr. Ferdnand Osuagwu, who was the former Chair of the Caucus on Climate Change and Mental Health of the American Psychiatric Association (APA) and founder of the Ferdnand Foundation International, an organization dedicated to underserved and marginalized populations and with a particular emphasis on addressing their needs in the areas of health, education, climate change, social justice and resource mobilization.

    
    

    Ferdnand Foundation Website: https://ferdnandfoundation.org/

    Ferdnand Foundation Youtube Channel: https://www.youtube.com/@FerdnandFoundation/featured

25. Introduction to Benzodiazepines

    October 15, 202522 minPlay next

    Today, we are talking about a very popular, yet controversial class of medications - the Benzodiazepines . Let's look at their mechanism of action, clinical indications, pharmacology, risks, withdrawal …

    Show notes

    Today, we are talking about a very popular, yet controversial class of medications - the Benzodiazepines . Let's look at their mechanism of action, clinical indications, pharmacology, risks, withdrawal syndromes, and prescribing guidance. And of course, we'll be tackling the question: what are the risks and benefits of long-term use?

    
    

    References:

    • https://pubmed.ncbi.nlm.nih.gov/30098211/

    • https://pubmed.ncbi.nlm.nih.gov/32252539/

    • https://nida.nih.gov/research-topics/trends-statistics/overdose-death-rates

    • https://aapp.org/guideline/benzo

    • https://pubmed.ncbi.nlm.nih.gov/40526204/

    • https://pmc.ncbi.nlm.nih.gov/articles/PMC6097846/

    • https://www.ncbi.nlm.nih.gov/books/NBK470159/

    • https://www.cambridge.org/core/journals/advances-in-psychiatric-treatment/article/benzodiazepines-for-anxiety-disorders-maximising-the-benefits-and-minimising-the-risks/43A366723CD1B3616BAB08F69FF65A88

26. Introduction to Anxiety Disorders

    October 8, 202526 minPlay next

    Welcome to an introductory episode on anxiety disorders as requested by a long-time listener. References:https://pmc.ncbi.nlm.nih.gov/articles/PMC5832062/https://pmc.ncbi.nlm.nih.gov/articles/PMC5573565/https:// …

    Show notes

    Welcome to an introductory episode on anxiety disorders as requested by a long-time listener.

    
    

    References:

    https://pmc.ncbi.nlm.nih.gov/articles/PMC5832062/

    https://pmc.ncbi.nlm.nih.gov/articles/PMC5573565/

    https://deepblue.lib.umich.edu/bitstream/handle/2027.42/175862/Nesse%20Anxiety%20Disorders%20in%20Evolutionary%20Perspective%202022.pdf?sequence=1

27. Loxapine (Loxitane) Revisited with Dr. Jonathan Meyer

    October 1, 202524 minPlay next

    Join us as we talk about Loxapine, an older medication that’s stood the test of time and found a niche in psychiatric practice. This is a revision of an earlier episode, after Dr. Bradley Miller chatted with …

    Show notes

    Join us as we talk about Loxapine, an older medication that’s stood the test of time and found a niche in psychiatric practice. This is a revision of an earlier episode, after Dr. Bradley Miller chatted with Dr. Jonathan Meyer at the 2025 APA Conference. Dr. Meyer joins us at the beginning to provide an addendum to the original episode.

28. Pregabalin (Lyrica)

    September 24, 202514 minPlay next

    Welcome back! Today, we will be talking about Pregabalin, brand-name Lyrica, a similar medication to Gabapentin, and we will specifically be focusing on its use in psychiatry. What are its benefits and …

    Show notes

    Welcome back! Today, we will be talking about Pregabalin, brand-name Lyrica, a similar medication to Gabapentin, and we will specifically be focusing on its use in psychiatry. What are its benefits and drawbacks compared to Gabapentin?

    
    

    Sources:

    - https://pubmed.ncbi.nlm.nih.gov/33563173/

    - https://pubmed.ncbi.nlm.nih.gov/39989902/

    - https://pmc.ncbi.nlm.nih.gov/articles/PMC3699256/

    - https://pubmed.ncbi.nlm.nih.gov/33563173/

    
    

29. Gabapentin (Neurontin)

    September 17, 202520 minPlay next

    Welcome back! Today, we will be talking about Gabapentin, brand-name Neurontin, one of the most commonly-prescribed medications in the United States, and we will specifically be focusing on its use in …

    Show notes

    Welcome back! Today, we will be talking about Gabapentin, brand-name Neurontin, one of the most commonly-prescribed medications in the United States, and we will specifically be focusing on its use in psychiatry. It is commonly prescribed for anxiety disorders, alcohol use disorder, and sometimes even bipolar disorder! But what does the evidence say?

    
    

    Sources:

    • https://pmc.ncbi.nlm.nih.gov/articles/PMC3619699/#:~:text=The%20FDA%20approved%20gabapentin%20enacarbil,legs%20syndrome%20(RLS)%20symptoms.

    • https://journals.lww.com/intclinpsychopharm/Abstract/2017/01000/Pregabalin_for_generalized_anxiety_disorder__an.8.aspx

    • https://pmc.ncbi.nlm.nih.gov/articles/PMC9507147/

    • https://pmc.ncbi.nlm.nih.gov/articles/PMC4732322/

    • https://pubmed.ncbi.nlm.nih.gov/9263379/

    • https://pubmed.ncbi.nlm.nih.gov/28988943/

    • https://www.cdc.gov/mmwr/volumes/71/wr/mm7119a3.htm

30. Trauma and The Neurosequential Model of Therapeutics with Dr. Bruce Perry

    September 10, 20251 h 1 minPlay next

    Welcome back! Today, we have renowned guest Dr. Bruce Perry, one of the world's most influential child psychiatrists, to talk to us about his approach to trauma. We will go over Dr. Perry's Neurosequential …

    Show notes

    Welcome back! Today, we have renowned guest Dr. Bruce Perry, one of the world's most influential child psychiatrists, to talk to us about his approach to trauma. We will go over Dr. Perry's Neurosequential Model of Therapeutics, which integrates neuroscience with child development. Dr. Perry is also a respected author, co-writing books like The Boy Who Was Raised As a Dog, Born for Love: Why Empathy is Essential and Endangered, as well as What Happened to You? Conversations on Trauma, Resilience and Healing.

    
    

    Dr. Perry's Website: https://www.bdperry.com/

    Dr. Perry's Books: https://www.amazon.com/Books-Bruce-Perry/s?rh=n%3A283155%2Cp_27%3ABruce%2BPerry

    Dr. Perry's Youtube Channel: https://www.youtube.com/@infonmn326

These are the latest 40 of 121 episodes. You’ll find older episodes in the podcast’s feed.